235 related articles for article (PubMed ID: 3294051)
1. [Pancreatic polypeptide response to oral glucose load in patients with liver cirrhosis--interrelationship between PP and other pancreatic endocrine hormones].
Kawakami K
Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):155-70. PubMed ID: 3294051
[TBL] [Abstract][Full Text] [Related]
2. Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Sakai T; Ohneda A; Nihei J; Kobayashi T
Tohoku J Exp Med; 1982 Dec; 138(4):427-40. PubMed ID: 6761899
[TBL] [Abstract][Full Text] [Related]
3. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
4. Degradation and secretion of insulin in hepatic cirrhosis.
Iwasaki Y; Ohkubo A; Kajinuma H; Akanuma Y; Kosaka K
J Clin Endocrinol Metab; 1978 Oct; 47(4):774-9. PubMed ID: 400732
[TBL] [Abstract][Full Text] [Related]
5. Hormonal Responses to Cholinergic Input Are Different in Humans with and without Type 2 Diabetes Mellitus.
Chowdhury S; Wang S; Dunai J; Kilpatrick R; Oestricker LZ; Wallendorf MJ; Patterson BW; Reeds DN; Wice BM
PLoS One; 2016; 11(6):e0156852. PubMed ID: 27304975
[TBL] [Abstract][Full Text] [Related]
6. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.
Grancini V; Trombetta M; Lunati ME; Zimbalatti D; Boselli ML; Gatti S; Donato MF; Resi V; D'Ambrosio R; Aghemo A; Pugliese G; Bonadonna RC; Orsi E
J Hepatol; 2015 Dec; 63(6):1484-90. PubMed ID: 26297917
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma levels of glucagon-like peptide-1 after oral glucose ingestion in patients with pancreatic diabetes.
Hiroyoshi M; Tateishi K; Yasunami Y; Maeshiro K; Ono J; Matsuoka Y; Ikeda S
Am J Gastroenterol; 1999 Apr; 94(4):976-81. PubMed ID: 10201468
[TBL] [Abstract][Full Text] [Related]
8. [Pancreatic hormone secretion in patients with newly detected diabetes mellitus].
Belovalova IM; Kniazeva AP; Starosel'tseva LK; Perelygina AA
Probl Endokrinol (Mosk); 1988; 34(6):3-6. PubMed ID: 3070538
[TBL] [Abstract][Full Text] [Related]
9. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
[TBL] [Abstract][Full Text] [Related]
10. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
11. Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.
Matsumoto K; Miyake S; Yano M; Ueki Y; Yamaguchi Y; Akazawa S; Tominaga Y
Diabetes Care; 1997 Oct; 20(10):1562-8. PubMed ID: 9314636
[TBL] [Abstract][Full Text] [Related]
12. Abnormal pancreatic polypeptide response to oral glucose loading diabetes mellitus.
Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Mori K; Imura H
Clin Endocrinol (Oxf); 1980 Nov; 13(5):425-9. PubMed ID: 7226566
[TBL] [Abstract][Full Text] [Related]
13. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
[TBL] [Abstract][Full Text] [Related]
14. [Behavior of plasma insulin, C-peptide and glucagon in normal subjects and in patients with liver cirrhosis].
Gragnoli G; Tanganelli I; Signorini AM
Boll Soc Ital Biol Sper; 1980 Jan; 56(1):69-75. PubMed ID: 7002168
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of insulin, C-peptide and glucagon in liver cirrhosis.
Gragnoli G; Signorini AM; Tanganelli I
J Endocrinol Invest; 1981; 4(1):1-5. PubMed ID: 7016966
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretion after oral calcium load.
Fujita T; Sakagami Y; Tomita T; Okamoto Y; Oku H
Endocrinol Jpn; 1978 Dec; 25(6):645-8. PubMed ID: 751809
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of body weight, hyperinsulinemia and oral glucose load on serum C-peptide/insulin molar ratio.
Okada N; Kobayashi M; Ohtsuka H; Shigematsu S; Nagasawa Y; Komatsu M; Aizawa T; Yamada T
Horm Metab Res; 1992 Sep; 24(9):429-33. PubMed ID: 1427614
[TBL] [Abstract][Full Text] [Related]
18. Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance.
Lanng S; Thorsteinsson B; Røder ME; Orskov C; Holst JJ; Nerup J; Koch C
Acta Endocrinol (Copenh); 1993 Mar; 128(3):207-14. PubMed ID: 8480468
[TBL] [Abstract][Full Text] [Related]
19. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
Snehalatha C; Ramachandran A; Satyavani K; Latha E; Viswanathan V
Diabetes Care; 1998 Jan; 21(1):76-9. PubMed ID: 9538973
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of revised fasting plasma glucose criterion and characteristics of the insulin response to an oral glucose load in newly diagnosed Japanese diabetic subjects.
Tanaka Y; Atsumi Y; Asahina T; Hosokawa K; Matsuoka K; Kinoshita J; Onuma T; Kawamori R
Diabetes Care; 1998 Jul; 21(7):1133-7. PubMed ID: 9653608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
